Home Allakos

Allakos

In operation
Targeted issuance
Antibody Therapy Developer

Basic Information

Allakos is a biotechnology company dedicated to developing antibody-based therapies to treat diseases in which dysregulated T-helper type 2 immune responses play a key role in pathology, including allergic conditions, inflammation, and diseases characterized by excessive production of inflammatory cells.
Allakos Inc.
Redwood City,California,United States of America
51~100 people
January 01, 2012
info@allakos.com